Gostrongx Posted - 6 days ago

$AMRX cmon RFK news isn’t going to hurt generics

Gostrongx Posted - 1 week ago

$AMRX news highs.

Gostrongx Posted - 1 week ago

$AMRX heading for 9. Let’s go

RomanGPT Posted - 1 week ago

$AMRX they will go to 10 soon

FlynancialAnalyst Posted - 1 week ago

$AMRX $2.70B mc $XLV Drug manufacturer with a noteworthy hammer close and protection of 10 wk SMA on volume Co-Founder led by two brothers, 54.31% insider owned! Short float % in a long-term downtrend Pct of all funds long shares at 2yr highs & rising TrendEdge.app/asset/AMRX

Stocksrunner Posted - 1 week ago

🚀 Epic Comeback Alert! From session lows to BEAST MODE: $ENSC $AMRX $AEYE $TPIC $MIST crushing it with that V-shape recovery! Never underestimate a stock's resilience! This is why we don't panic sell at the bottom!

DirkInvest Posted - 1 week ago

$AMRX Whats with the R&D milestone, anyone knows? Do I understand it correctly they had to pay, rather than receive, a 20 million milestone? So R&D costs increased 20 million in the earnings, so this means they put the milestone under these R&D costs? If this is only a one-time thing, its no wonder they have a net loss now. It would've been +19.8 million profit without it, despite the increased interest expenses. Revenue beats guidance, so the earnings are in fact much better then what my first glance at the summary made me think.

DonCorleone77 Posted - 1 week ago

$AMRX Amneal Pharmaceuticals backs FY24 adjusted EPS view 57c-63c, consensus 60c Backs FY24 revenue view $2.7B-$2.8B, consensus $2.76B. Backs FY24 adjusted EBITDA $610M-$630M.

DonCorleone77 Posted - 1 week ago

$AMRX Amneal Pharmaceuticals reports Q3 adjusted EPS 16c, consensus 13c Reports Q3 revenue $702M, consensus $696.8M. "Q3 was an excellent quarter where we continued to drive strong financial results across our diversified business and we announced three strategic actions to solidify our long-term growth. First, we launched Crexont for the treatment of Parkinson's disease. Second, we announced our collaboration with Metsera, Inc. to leverage Amneal's expertise and supply next-generation medicines for obesity and metabolic diseases. Third, we expanded our deep pipeline by in-licensing a new high-value biosimilar. We look forward to building on our momentum and continuing to create value for all our key stakeholders," said Chirag and Chintu Patel, Co-Chief Executive Officers.

Gostrongx Posted - 1 week ago

$AMRX numbers still going well

DirkInvest Posted - 1 week ago

$AMRX I'm content with the earnings. Nothing too special but just in line to expectations and decent increase in revenue.

DirkInvest Posted - 2 weeks ago

$AMRX Wonder what we will see on friday. Quite some new drugs launched recently, but too early still to have those bring in any significant revenue yet. In fact, launch related costs might negatively impact the profit this quarter. Still having good feelings, hoping for a small profit. Fingers crossed!

Gostrongx Posted - 2 weeks ago

$AMRX did the ER report leak ?

Dkll303 Posted - 2 weeks ago

$AGIO $AMRX $CPRX $IDYA you bring nothing to agios , you clown Join @EingeLTrade ..he is long gone with his golden cross and a BO What is today here , short covering once again !!! hahaha

Estimize Posted - 2 weeks ago

Wall St is expecting 0.13 EPS for $AMRX Q3 [Reporting 11/08 BMO] http://www.estimize.com/intro/amrx?chart=historical&metric_name=eps&utm_co

Gostrongx Posted - 10/28/24

$AMRX can the Chirags bros surprise again with earnings and send us into double digits?!

WeeklyTrader Posted - 10/23/24

How are you handling the drop in $AMRX? RSI: 49.53% 50-day MA: $8.46 200-day MA: $6.79

G101SPM Posted - 1 month ago

$AMRX $8.71 bid. DAC (dollar average cost) 8.20 (8.20.24). CHANGE EXIT TO $16.00 from $11.00 (long term). UPDATE: Co announced that it has received FDA approval of its New Drug Application for Pyridostigmine Bromide Extended-Release (PB ER) Tablets USP 105 mg. PB ER 105 mg tablets are a once-daily, orally administered product indicated for pretreatment against the lethal effects of soman nerve agent poisoning in adults developed for the U.S. Armed Services and U.S. allies. note: Project was funded in part by the U.S. government under Agreement W911QY-21-9-0018.

DirkInvest Posted - 1 month ago

$AMRX Another FDA approval 🥱

swingingtech Posted - 1 month ago

$CORT $AMRX https://wallstreetwaves.com/corcept-cort-shows-promising-growth-will-its-recent-5-5-surge-lead-to-continued-momentum/

Outtatowner Posted - 1 month ago

$AMRX 👀 Going to surprise some people this week

GhostxSwings Posted - 1 month ago

Great longer time frame swing $AMRX

Gostrongx Posted - 1 month ago

$AMRX knocking on $9. Let’s go. On to $12

Gostrongx Posted - 1 month ago

$AMRX

net0trader Posted - 1 month ago

$AMRX break out watch. Above 9 could get see 14+. My top setup @MaverikIT @IsabellaDC

Gostrongx Posted - 1 month ago

$AMRX

StockConsultant Posted - 1 month ago

$AMRX Amneal Pharmaceuticals stock, watch for a top of range breakout

SmartestMoney Posted - 1 month ago

$AMRX Double

WeeklyTrader Posted - 1 month ago

What’s causing you to feel bearish on $AMRX? RSI: 55.53% 50-day MA: $8.3 200-day MA: $6.71

Gostrongx Posted - 1 month ago

$AMRX stuck in this trading range of 8.50. Earnings is 1st week of November. So should see this climb. Last 3 qtrs have been great. Let’s get to $12!